"If Washington Isn't Careful, We Might Leave Innovation Behind"

June 26, 2019

"Trying to make medications more affordable is important, but if Washington isn't careful, we might leave innovation behind." This is the message the Pharmaceutical Research and Manufacturers of America (PhRMA) heard from Amy, a Voters for Cures advocate from South Carolina who reminds us what's at stake in the broader public policy debate around medical innovation, access and affordability.